This compound is a pharmaceutical intermediate used in the synthesis of antiviral agents. It features a phosphoramidate structure with an ester linkage and an aromatic ring.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1355049-92-1
SCHEMBL14125267
pharmaceutical intermediate
Tert-butyl (6S)-6-[5-(7-bromo-9,9-difluorofluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylate
pharmaceutical intermediate
1H-1,2,4-Triazole-1-carboxamidine hydrochloride
pharmaceutical intermediate
Methyl (2S)-2-{[(tert-butoxy)carbonyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propanoate
pharmaceutical intermediate
(3R,4R,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-ol
pharmaceutical intermediate
(2R,3R,4R,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolane-2-carbonitrile
pharmaceutical intermediate
Bis valacyclovir
pharmaceutical intermediate
(4S)-2-(((R)-2-amino-2-(4-hydroxyphenyl)acetamido)methyl(-5,5-dimethylthiazolidine-4-carboxylic acid
pharmaceutical intermediate
2-ethylbutyl (2S)-2-[[chloro(phenoxy)phosphoryl]amino]propanoate
AFQRGLCAHXLJJE-BJDAYTSDSA-N
CCC(CC)COC(=O)[C@H](C)NP(=O)(OC1=CC=CC=C1)Cl